Jonathan Kil, MD

CMO
Sound Pharmaceuticals
Seattle, WA, United States

Jonathan Kil, MD is the Co-Founder, CEO and CMO of Sound Pharmaceutcials. He is developing the first drugs to treat hearing loss and tinnitus and has lead the completion of multiple clinical trials in the new therapeutic area. Dr. Kil serves on the Boards or as a Trustee of UW/Harborview Medical Center, Life Science Washington, and the Woodland Park Zoo. he is an advisor the Fred Hutch Cancer Center, Seattle Childrens, and the DoD.

Presentation(s):

• SPI-1005 (Ebselen) Reduces Low Frequency Hearing Loss After Cochlear Implantation in Guinea Pigs

  Sunday, September 29, 2024
  2:48 PM – 2:54 PM EDT

  Disclosure(s):

  faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.